1887

Abstract

The ARTIC protocol uses a multiplexed PCR approach with two primer pools tiling the entire SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) genome. Primer pool updates are necessary for accurate amplicon sequencing of evolving SARS-CoV-2 variants with novel mutations. The suitability of the ARTIC V4 and updated V4.1 primer scheme was assessed using whole genome sequencing of Omicron from clinical samples using Oxford Nanopore Technology. Analysis of Omicron BA.1 genomes revealed that 93.22 % of clinical samples generated improved genome coverage at 50× read depth with V4.1 primers when compared to V4 primers. Additionally, the V4.1 primers improved coverage of BA.1 across amplicons 76 and 88, which resulted in the detection of the variant-defining mutations G22898A, A26530G and C26577G. The Omicron BA.2 sub-variant (VUI-22JAN-01) replaced BA.1 as the dominant variant by March 2022, and analysis of 168 clinical samples showed reduced coverage across amplicons 15 and 75. Upon further interrogation of primer binding sites, a mutation at C4321T [present in 163/168 (97 %) of samples] was identified as a possible cause of complete dropout of amplicon 15. Furthermore, two mutations were identified within the primer binding regions for amplicon 75: A22786C (present in 90 % of samples) and C22792T (present in 12.5 % of samples). Together, these mutations may result in reduced coverage of amplicon 75, and further primer updates would allow the identification of the two BA.2-defining mutations present in amplicon 75: A22688G and T22679C. This work highlights the need for ongoing surveillance of primer matches as circulating variants evolve and change.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000991
2023-04-21
2024-04-28
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/4/mgen000991.html?itemId=/content/journal/mgen/10.1099/mgen.0.000991&mimeType=html&fmt=ahah

References

  1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int
  2. Nadeau S, Beckmann C, Topolsky I, Vaughan T, Hodcroft E et al. Quantifying SARS-CoV-2 spread in Switzerland based on genomic sequencing data. medRxiv 2020 [View Article]
    [Google Scholar]
  3. Martin J, Klapsa D, Wilton T, Zambon M, Bentley E et al. Tracking SARS-CoV-2 in sewage: evidence of changes in virus variant predominance during COVID-19 pandemic. Viruses 2020; 12:1144 [View Article] [PubMed]
    [Google Scholar]
  4. Volz E, Mishra S, Chand M, Barrett JC, Johnson R et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. medRxiv 2021 [View Article]
    [Google Scholar]
  5. Chen C, Nadeau S, Yared M, Voinov P, Xie N et al. CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variants. Bioinformatics 2022; 38:1735–1737 [View Article]
    [Google Scholar]
  6. Gram MA, Emborg H-D, Schelde AB, Friis NU, Nielsen KF et al. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. PLoS Med 2022; 19:e1003992 [View Article] [PubMed]
    [Google Scholar]
  7. Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N Engl J Med 2022; 386:1532–1546 [View Article] [PubMed]
    [Google Scholar]
  8. Kirsebom FCM, Andrews N, Stowe J, Toffa S, Sachdeva R et al. COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England. Lancet Infect Dis 2022; 22:931–933 [View Article] [PubMed]
    [Google Scholar]
  9. Quick J. nCoV-2019 sequencing protocol V.1. protocols.io. ARTIC 2020 [View Article]
    [Google Scholar]
  10. Quick J. nCoV-2019 sequencing protocol v2 (GunIt) V.2. protocols.io; 2019 [View Article]
  11. Quick J. nCoV-2019 sequencing protocol v3 (LoCost). protocols.io. n.d
  12. Tyson JR, James P, Stoddart D, Sparks N, Wickenhagen A et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv 20202020.09.04.283077 [View Article] [PubMed]
    [Google Scholar]
  13. ARTIC Network SARS-CoV-2 V4.1 update for Omicron variant; 2021 https://community.artic.network/t/sars-cov-2-v4-1-update-for-omicron-variant/342
  14. ARTIC Network SARS-CoV-2 version 4 scheme release. n.d https://community.artic.network/t/sars-cov-2-version-4-scheme-release/312
  15. Davis JJ, Long SW, Christensen PA, Olsen RJ, Olson R et al. Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein. Microbiol Spectr 2021; 9:e0180321 [View Article] [PubMed]
    [Google Scholar]
  16. O’Toole Á, Scher E, Underwood A, Jackson B, Hill V et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol 2021; 7:veab064 [View Article] [PubMed]
    [Google Scholar]
  17. Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 2020; 5:1403–1407 [View Article] [PubMed]
    [Google Scholar]
  18. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 2002; 30:3059–3066 [View Article] [PubMed]
    [Google Scholar]
  19. Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ. Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009; 25:1189–1191 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000991
Loading
/content/journal/mgen/10.1099/mgen.0.000991
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Supplementary material 3

EXCEL

Supplementary material 4

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error